Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Trastuzumab Rezatecan and Retlirafusp alfa
DRUG
2 trials
Sponsors
The First Affiliated Hospital with Nanjing Medical University
Conditions
Gastric or Gastroesophageal Junction Adenocarcinoma
Phase 1
Neoadjuvant SHR-A1811 and SHR-A1701 for Potentially Immunotherapy-Sensitive GC or GEJ Adenocarcinoma
Not yet recruiting
NCT07581574
The First Affiliated Hospital with Nanjing Medical University
Gastric or Gastroesophageal Junction Adenocarcinoma
Start: 2026-05-01
End: 2029-05-31
Target: 12
Updated: 2026-05-18
Phase 2
Neoadjuvant SHR-A1811 and SHR-A1701 ± Pertuzumab for Potentially Immunotherapy-Sensitive GC or GEJ Adenocarcinoma
Not yet recruiting
NCT07716111
The First Affiliated Hospital with Nanjing Medical University
Gastric or Gastroesophageal Junction Adenocarcinoma
Start: 2026-07-16
End: 2029-08-31
Target: 24
Updated: 2026-07-21